| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | Nov 18, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 51.3 | -782 | -0.01% | ✗ | $25.9K |
| Mar 1, 2024 | Mar 5, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 40.0 | -46,534 | -1.98% | ✓ | $1.4M |
| Feb 26, 2024 | Feb 28, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 37.5 | -807,838 | -1.59% | ✓ | $19.6M |
| Feb 21, 2024 | Feb 23, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 37.5 | -500,789 | -1.72% | ✓ | $11.3M |
| Feb 15, 2024 | Feb 20, 2024 | Dyne Therapeutics, Inc. | Director | Sell | 25.0 | -510,152 | -6.96% | ✓ | $11.9M |
| Dec 12, 2022 | Dec 14, 2022 | Dyne Therapeutics, Inc. | Director | Buy | 100.0 | +934,581 | 100.00% | ✗ | $10M |
| Sep 27, 2021 | Sep 29, 2021 | Generation Bio Co. | Director | Sell | 5.0 | -81,088 | -62.76% | ✓ | $2.1M |
| Sep 22, 2021 | Sep 24, 2021 | Generation Bio Co. | Director | Sell | 10.0 | -134,998 | -21.66% | ✓ | $3.5M |
| Jun 24, 2021 | Jun 28, 2021 | Generation Bio Co. | Director | Sell | 7.5 | -31,008 | -85.37% | ✓ | $801.6K |
| Jun 21, 2021 | Jun 23, 2021 | Generation Bio Co. | Director | Sell | 10.0 | -185,078 | -23.14% | ✓ | $4.6M |
| Apr 12, 2021 | Apr 14, 2021 | Generation Bio Co. | Director | Sell | 5.0 | -140,682 | -100.00% | ✓ | $3.6M |
| Apr 7, 2021 | Apr 9, 2021 | Generation Bio Co. | Director | Sell | 5.0 | -127,095 | -47.46% | ✓ | $3.6M |
| Jan 26, 2021 | Jan 28, 2021 | Replimune Group, Inc. | Director | Sell | 45.0 | -5,558 | -0.58% | ✓ | $256.4K |
| Dec 18, 2020 | Dec 22, 2020 | Replimune Group, Inc. | Director | Sell | 50.0 | -4,319 | -0.13% | ✓ | $181.2K |
| Dec 15, 2020 | Dec 17, 2020 | Replimune Group, Inc. | Director | Sell | 43.8 | -65,029 | -0.40% | ✓ | $2.7M |
| Dec 10, 2020 | Dec 14, 2020 | Replimune Group, Inc. | Director | Sell | 43.8 | -103,686 | -0.39% | ✓ | $4.5M |
| Dec 7, 2020 | Dec 9, 2020 | Replimune Group, Inc. | Director | Sell | 41.3 | -217,362 | -0.67% | ✓ | $10M |
| Nov 18, 2019 | Nov 20, 2019 | Replimune Group, Inc. | Director | Buy | 100.0 | +1,100,000 | 100.00% | ✗ | $15M |